See more : Dabur India Limited (DABUR.NS) Income Statement Analysis – Financial Results
Complete financial analysis of EL.En. S.p.A. (ELN.MI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EL.En. S.p.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- Sterling Bancorp, Inc. (Southfield, MI) (SBT) Income Statement Analysis – Financial Results
- KHVATEC Co.,Ltd. (060720.KQ) Income Statement Analysis – Financial Results
- The MEDIA GLOBO Corporation (MGLO) Income Statement Analysis – Financial Results
- Ardmore Shipping Corporation (ASC) Income Statement Analysis – Financial Results
- Flag Ship Acquisition Corp. Ordinary Shares (FSHP) Income Statement Analysis – Financial Results
EL.En. S.p.A. (ELN.MI)
About EL.En. S.p.A.
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 692.29M | 673.58M | 571.40M | 408.08M | 400.76M | 346.02M | 306.46M | 252.65M | 217.67M | 180.01M | 157.38M | 151.23M | 211.14M | 189.80M | 149.11M | 221.67M | 193.44M | 154.37M | 124.32M | 99.49M | 72.93M |
Cost of Revenue | 440.21M | 430.11M | 365.32M | 272.18M | 248.21M | 214.15M | 183.44M | 145.34M | 123.68M | 100.54M | 84.81M | 81.92M | 104.52M | 99.63M | 71.65M | 97.16M | 67.07M | 76.10M | 58.93M | 64.46M | 49.46M |
Gross Profit | 252.08M | 243.47M | 206.09M | 135.90M | 152.55M | 131.87M | 123.02M | 107.31M | 93.99M | 79.47M | 72.57M | 69.31M | 106.61M | 90.17M | 77.46M | 124.51M | 126.37M | 78.27M | 65.39M | 35.03M | 23.46M |
Gross Profit Ratio | 36.41% | 36.15% | 36.07% | 33.30% | 38.06% | 38.11% | 40.14% | 42.47% | 43.18% | 44.15% | 46.11% | 45.83% | 50.49% | 47.51% | 51.95% | 56.17% | 65.33% | 50.70% | 52.60% | 35.21% | 32.17% |
Research & Development | 372.11K | 19.95M | 19.78M | 16.07M | 15.01M | 16.22M | 12.94M | 10.40M | 9.21M | 8.48M | 7.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 162.16M | 6.83M | 5.77M | 4.55M | 5.08M | 4.78M | 4.09M | 3.70M | 3.73M | 3.14M | 3.39M | 3.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 12.93M | 10.12M | 6.73M | 6.06M | 10.46M | 10.59M | 8.05M | 7.50M | 6.53M | 5.49M | 5.14M | 5.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 167.48M | 16.95M | 12.50M | 10.61M | 15.54M | 15.37M | 12.14M | 11.19M | 10.26M | 8.63M | 8.53M | 9.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 11.50M | 151.21M | 134.29M | 100.59M | 101.91M | 91.77M | 84.30M | 71.39M | 64.06M | 57.56M | 56.10M | 55.05M | 103.63M | 92.82M | 90.06M | 103.96M | 105.07M | 72.81M | 58.88M | -1.10M | -550.83K |
Operating Expenses | 181.34M | 168.16M | 146.79M | 111.20M | 117.45M | 107.14M | 96.44M | 82.58M | 74.31M | 66.19M | 64.63M | 64.11M | 103.63M | 92.82M | 90.06M | 103.96M | 105.07M | 72.81M | 58.88M | -1.10M | -550.83K |
Cost & Expenses | 619.55M | 598.28M | 512.11M | 383.38M | 365.66M | 321.29M | 279.88M | 227.92M | 197.99M | 166.73M | 149.44M | 146.03M | 208.16M | 192.45M | 161.71M | 201.12M | 172.14M | 148.91M | 117.82M | 64.46M | 49.46M |
Interest Income | 1.15M | 601.13K | 651.21K | 587.48K | 549.26K | 694.54K | 736.53K | 627.93K | 645.49K | 643.10K | 641.87K | 357.39K | 2.18M | 1.56M | 2.38M | 4.21M | 3.94M | 3.34M | 1.83M | 0.00 | 0.00 |
Interest Expense | 3.04M | 410.04K | 259.65K | 323.54K | 300.55K | 161.99K | 307.19K | 409.00K | 586.40K | 638.56K | 687.87K | 763.95K | 4.14M | 1.51M | 1.44M | 2.58M | 3.24M | 1.22M | 907.55K | 25.13M | 20.47M |
Depreciation & Amortization | 11.83M | 10.09M | 8.71M | 7.90M | 6.89M | 4.42M | 3.83M | 3.60M | 5.24M | 7.73M | 4.10M | 2.25M | 7.35M | 6.41M | 10.28M | 5.07M | 5.04M | 3.35M | 1.49M | 4.79M | 3.50M |
EBITDA | 83.94M | 90.71M | 76.59M | 37.18M | 46.59M | 36.07M | 32.44M | 31.17M | 24.53M | 16.24M | 12.12M | 9.79M | 8.22M | 11.75M | -5.56M | 28.38M | 39.39M | 9.67M | 33.64M | 7.43M | 26.42M |
EBITDA Ratio | 12.12% | 13.31% | 13.13% | 8.76% | 11.34% | 9.79% | 10.01% | 13.34% | 12.28% | 12.80% | 8.69% | 6.43% | 6.61% | 7.94% | -1.56% | 14.85% | 13.62% | 8.82% | 9.21% | 38.92% | 36.22% |
Operating Income | 72.74M | 81.00M | 64.86M | 30.11M | 38.20M | 29.99M | 30.45M | 27.59M | 21.50M | 15.30M | 9.58M | 7.47M | 6.61M | 8.67M | -12.60M | 27.86M | 21.30M | 10.26M | 9.95M | 33.93M | 22.91M |
Operating Income Ratio | 10.51% | 12.03% | 11.35% | 7.38% | 9.53% | 8.67% | 9.94% | 10.92% | 9.88% | 8.50% | 6.09% | 4.94% | 3.13% | 4.57% | -8.45% | 12.57% | 11.01% | 6.65% | 8.00% | 34.10% | 31.42% |
Total Other Income/Expenses | -1.60M | -2.01M | 1.76M | -2.19M | 445.52K | -441.95K | -3.23M | 25.13M | 1.61M | 9.11M | 1.11M | -1.38M | -328.95K | -412.63K | 544.66K | -5.77M | 14.10M | 1.88M | 20.57M | 3.42M | -21.25M |
Income Before Tax | 71.13M | 78.99M | 66.42M | 27.92M | 38.64M | 29.55M | 27.22M | 52.72M | 23.11M | 24.41M | 10.69M | 6.09M | 2.46M | 4.69M | -12.33M | 22.09M | 35.40M | 7.18M | 30.52M | 8.44M | 2.21M |
Income Before Tax Ratio | 10.28% | 11.73% | 11.62% | 6.84% | 9.64% | 8.54% | 8.88% | 20.87% | 10.62% | 13.56% | 6.80% | 4.03% | 1.17% | 2.47% | -8.27% | 9.96% | 18.30% | 4.65% | 24.55% | 8.49% | 3.04% |
Income Tax Expense | 21.07M | 19.95M | 17.30M | 5.38M | 9.87M | 7.71M | 6.81M | 9.73M | 7.06M | 6.41M | 4.28M | 2.95M | 2.75M | 4.26M | 4.06M | 7.87M | 10.46M | 4.54M | 4.41M | 3.36M | 1.84M |
Net Income | 48.24M | 55.11M | 45.44M | 20.26M | 26.02M | 16.79M | 15.63M | 40.41M | 14.37M | 16.52M | 6.08M | 3.14M | -288.81K | 433.55K | -16.39M | 14.22M | 24.94M | 2.64M | 26.11M | 5.44M | 376.17K |
Net Income Ratio | 6.97% | 8.18% | 7.95% | 4.96% | 6.49% | 4.85% | 5.10% | 15.99% | 6.60% | 9.18% | 3.86% | 2.08% | -0.14% | 0.23% | -10.99% | 6.41% | 12.89% | 1.71% | 21.00% | 5.47% | 0.52% |
EPS | 0.60 | 0.69 | 0.57 | 0.26 | 0.34 | 0.22 | 0.20 | 0.52 | 0.19 | 0.21 | 0.08 | 0.04 | 0.00 | 0.02 | -0.22 | 0.11 | 0.23 | 0.02 | 0.33 | 0.06 | 0.00 |
EPS Diluted | 0.59 | 0.69 | 0.57 | 0.25 | 0.32 | 0.21 | 0.20 | 0.52 | 0.19 | 0.21 | 0.08 | 0.04 | 0.00 | 0.02 | -0.22 | 0.11 | 0.23 | 0.02 | 0.33 | 0.06 | 0.00 |
Weighted Avg Shares Out | 79.97M | 79.80M | 79.48M | 78.34M | 77.36M | 77.21M | 77.21M | 77.34M | 77.16M | 77.19M | 77.19M | 76.85M | 72.09M | 77.19M | 75.54M | 75.91M | 76.51M | 75.02M | 74.58M | 73.60M | 0.00 |
Weighted Avg Shares Out (Dil) | 81.76M | 79.80M | 79.48M | 80.22M | 80.67M | 79.97M | 80.18M | 78.08M | 77.16M | 77.19M | 77.19M | 76.85M | 72.09M | 77.19M | 75.54M | 75.91M | 76.51M | 75.02M | 76.01M | 74.34M | 0.00 |
After the Great Success Achieved in the United States and Canada, DEKA Launches Three Extraordinary Laser and Microwave Platforms at the World Congress of Dermatology in Singapore
Source: https://incomestatements.info
Category: Stock Reports